Issue 12, 2023

Redox-dual-sensitive multiblock copolymer vesicles with disulfide-enabled sequential drug delivery

Abstract

Based on disulfide-enriched multiblock copolymer vesicles, we present a straightforward sequential drug delivery system with dual-redox response that releases hydrophilic doxorubicin hydrochloride (DOX·HCl) and hydrophobic paclitaxel (PTX) under oxidative and reductive conditions, respectively. When compared to concurrent therapeutic delivery, the spatiotemporal control of drug release allows for an improved combination antitumor effect. The simple and smart nanocarrier has promising applications in the field of cancer therapy.

Graphical abstract: Redox-dual-sensitive multiblock copolymer vesicles with disulfide-enabled sequential drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
09 Des. 2022
Accepted
03 Feb. 2023
First published
03 Feb. 2023

J. Mater. Chem. B, 2023,11, 2631-2637

Redox-dual-sensitive multiblock copolymer vesicles with disulfide-enabled sequential drug delivery

C. Cheng, J. Ma, J. Zhao, H. Lu, Y. Liu, C. He, M. Lu, X. Yin, J. Li and M. Ding, J. Mater. Chem. B, 2023, 11, 2631 DOI: 10.1039/D2TB02686D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements